Latest / Decera Clinical Education Oncology Podcast
PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape
In this episode, Philip Agop Philip, MD, PhD, FRCP, and Elena Gabriela Chiorean, MD, discuss the importance of testing for biomarkers along with thecurrent paradigm of PARP inhibitor therapy in the treatment of pancreatic cancer. Topics include:
Importance of germline and somatic testing
Adverse events associated with PARP inhibitors
Maintenance therapy in pancreatic cancer
Presenters:
Philip Agop Philip, MD, PhD, FRCP
Professor
School of Medicine
Wayne State University
Leader, Gastrointestinal Multidisciplinary Team
Department of Oncology
Karmanos Cancer Institute
Detroit, Michigan
Elena…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.